Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2018

Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2018

Summary

The clinical trial report, Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2018" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic Kidney Disease (Renal Anemia). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using the proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level


List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Anemia in Chronic Kidney Disease (Renal Anemia) 31
Jun 07, 2018: FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat in Anemia Associated with Chronic Kidney Disease 31
May 31, 2018: Astellas and FibroGen Announce Topline Results from Double-Blind Japan Phase 3 Study for Roxadustat in Hemodialysis Chronic Kidney Disease Patients with Anemia 31
Clinical Trial Profile Snapshots 32
Appendix 247
Abbreviations 247
Definitions 247
Research Methodology 248
Secondary Research 248
About GlobalData 249
Contact Us 249
Source 249

List Of Tables


Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials by Region, 2018* 8
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 16
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 19
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials by Phase, 2018* 22
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30

List Of Figures


Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials by Region (%), 2018* 8
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials, G7 Countries (%), 2018* 16
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18
Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials, E7 Countries (%), 2018* 19
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 29
Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 30
GlobalData Methodology 248

Aplastic Anemia - Pipeline Review, H2 2019

Aplastic Anemia - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Pipeline Review, H2 2019, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline

USD 2000 View Report

Fanconi Anemia - Pipeline Review, H2 2019

Fanconi Anemia - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2019, provides an overview of the Fanconi Anemia (Hematological Disorders) pipeline

USD 2000 View Report

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019

Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2019, provides an overview of

USD 2000 View Report

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2019

Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2019,

USD 2000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available